APA

Allen E. K., Randolph A. G., Bhangale T., Dogra P., Ohlson M., Oshansky C. M., Zamora A. E., Shannon J. P., Finkelstein D., Dressen A., DeVincenzo J., Caniza M., Youngblood B., Rosenberger C. M. & Thomas P. G. (20170911). SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. : Nature medicine.

Chicago

Allen E Kaitlynn, Randolph Adrienne G, Bhangale Tushar, Dogra Pranay, Ohlson Maikke, Oshansky Christine M, Zamora Anthony E, Shannon John P, Finkelstein David, Dressen Amy, DeVincenzo John, Caniza Miguela, Youngblood Ben, Rosenberger Carrie M and Thomas Paul G. 20170911. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. : Nature medicine.

Harvard

Allen E. K., Randolph A. G., Bhangale T., Dogra P., Ohlson M., Oshansky C. M., Zamora A. E., Shannon J. P., Finkelstein D., Dressen A., DeVincenzo J., Caniza M., Youngblood B., Rosenberger C. M. and Thomas P. G. (20170911). SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. : Nature medicine.

MLA

Allen E Kaitlynn, Randolph Adrienne G, Bhangale Tushar, Dogra Pranay, Ohlson Maikke, Oshansky Christine M, Zamora Anthony E, Shannon John P, Finkelstein David, Dressen Amy, DeVincenzo John, Caniza Miguela, Youngblood Ben, Rosenberger Carrie M and Thomas Paul G. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. : Nature medicine. 20170911.